Insider Trading Activity Abbott Laboratories (NYSE:ABT) – Insider Sold 2,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Abbott Laboratories (NYSE:ABT)

Sharon J Bracken , Insider of Abbott Laboratories (NYSE:ABT) reportedly Sold 2,000 shares of the company’s stock at an average price of 49.16 for a total transaction amount of $98,320.00 SEC Form

Insider Trading History For Abbott Laboratories (NYSE:ABT)

  • On 2/1/2013 William A Osborn, Director, bought 10,000 with an average share price of $33.86 per share and the total transaction amounting to $338,600.00.View SEC Filing
  • On 6/7/2013 Heather L Mason, SVP, sold 12,000 with an average share price of $37.01 per share and the total transaction amounting to $444,120.00.View SEC Filing
  • On 10/30/2013 Jaime Contreras, SVP, sold 25,368 with an average share price of $36.85 per share and the total transaction amounting to $934,810.80.View SEC Filing
  • On 11/7/2013 Stephen Fussell, EVP, sold 10,466 with an average share price of $37.59 per share and the total transaction amounting to $393,416.94.View SEC Filing
  • On 12/6/2013 Jean-Yves Pavee, SVP, sold 5,855 with an average share price of $37.46 per share and the total transaction amounting to $219,328.30.View SEC Filing
  • On 1/29/2014 Michael Warmuth, EVP, sold 11,430 with an average share price of $36.21 per share and the total transaction amounting to $413,880.30.View SEC Filing
  • On 2/18/2014 John Landgraf, EVP, sold 1,583 with an average share price of $39.10 per share and the total transaction amounting to $61,895.30.View SEC Filing

    • Analyst Ratings For Abbott Laboratories (NYSE:ABT)
    These are 3 Hold Ratings, 10 Buy Ratings .
    The current consensus rating for Abbott Laboratories (NYSE:ABT) is Buy (Score: 2.77) with a consensus target price of $52.58 , a potential (6.96% upside)

    Analyst Ratings History For Abbott Laboratories (NYSE:ABT)

    • On 1/29/2016 William Blair Downgraded rating Outperform to Market Perform
    • On 1/29/2016 Raymond James Financial, Inc. Lower Price Target of rating Outperform with a price target of $46.00 to $42.00
    • On 3/28/2016 Leerink Swann Boost Price Target of rating Market Perform with a price target of $37.00 to $40.00
    • On 4/14/2016 First Global Downgraded rating Outperform to Marketperform
    • On 4/28/2016 Piper Jaffray Companies Downgraded rating Overweight to Neutral
    • On 4/30/2016 Gabelli Reiterated Rating Buy
    • On 4/30/2016 S&P Equity Research Reiterated Rating Hold

    Dividend Information For Abbott Laboratories (NYSE:ABT)
    Abbott Laboratories (NYSE:ABT) pays an annual dividend of Community Ranking: with a yield of 2.16% and an average dividend growth of 22.90% (3 Year Average).

    Dividend History For Abbott Laboratories (NYSE:ABT)

  • On 12/14/2012 Abbott Laboratories announced a quarterly dividend of $0.14 0.86% with an ex dividend date of 1/11/2013 which will be payable on 2/15/2013.
  • On 2/15/2013 Abbott Laboratories announced a quarterly dividend of $0.14 1.61% with an ex dividend date of 4/11/2013 which will be payable on 5/15/2013.
  • On 6/14/2013 Abbott Laboratories announced a quarterly dividend of $0.14 1.52% with an ex dividend date of 7/11/2013 which will be payable on 8/15/2013.
  • On 9/12/2013 Abbott Laboratories announced a quarterly dividend of $0.14 1.61% with an ex dividend date of 10/10/2013 which will be payable on 11/15/2013.
  • On 10/16/2013 Abbott Laboratories announced a quarterly dividend of $0.22 2.37% with an ex dividend date of 1/13/2014 which will be payable on 2/15/2014.
  • On 2/21/2014 Abbott Laboratories announced a quarterly dividend of $0.22 2.26% with an ex dividend date of 4/11/2014 which will be payable on 5/15/2014.
  • On 6/13/2014 Abbott Laboratories announced a quarterly dividend of $0.22 2.21% with an ex dividend date of 7/11/2014 which will be payable on 8/15/2014.

    • Recent Trading Activity for Abbott Laboratories (NYSE:ABT)
    Shares of Abbott Laboratories closed the previous trading session at 49.16 down -0.07 -0.14% with 4,364,917 shares trading hands.